ACOR - Acorda Therapeutics Inc
IEX Last Trade
17.26
-0.340 -1.970%
Share volume: 11,619
Last Updated: Tue 08 Aug 2023 06:55:10 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$17.60
-0.34
-1.93%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-13 | 2022-08-09 | 2022-11-14 | 2023-03-15 | 2023-05-11 | 2023-08-09 | 2023-11-14 | |
| Assets | ||||||||
| Total Assets | 424.138 M | 406.312 M | 393.339 M | 395.595 M | 374.906 M | 364.696 M | 366.344 M | |
| Current Assets | 80.455 M | 76.522 M | 71.692 M | 82.115 M | 68.094 M | 64.914 M | 73.728 M | |
| Inventories | 14.836 M | 15.321 M | 15.252 M | 12.752 M | 13.465 M | 14.797 M | 17.942 M | |
| Other Current Assets | 8.363 M | 10.691 M | 7.822 M | 11.077 M | 8.195 M | 10.629 M | 10.480 M | |
| Short Term Investments | 8.363 M | 10.691 M | 7.822 M | 11.077 M | 8.195 M | 10.629 M | 10.480 M | |
| Total Receivables | 11.990 M | 14.270 M | 14.690 M | 13.866 M | 9.190 M | 13.390 M | 11.977 M | |
| Current Cash | 31.873 M | 23.127 M | 20.696 M | 37.536 M | 30.255 M | 25.270 M | 32.468 M | |
| Total Non-current Assets | 343.683 M | 329.790 M | 321.647 M | 313.480 M | 306.812 M | 299.782 M | 292.616 M | |
| Property Plant Equipment | 3.639 M | 3.023 M | 2.825 M | 2.603 M | 2.383 M | 2.163 M | 2.210 M | |
| Other Assets | 11.000 K | 248.000 K | 247.000 K | 248.000 K | 1.497 M | 2.899 M | 3.649 M | |
| Intangible Assets | 328.228 M | 320.472 M | 312.779 M | 305.087 M | 297.393 M | 289.700 M | 282.006 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 424.138 M | 406.312 M | 393.339 M | 395.595 M | 374.906 M | 364.696 M | 366.344 M | |
| Total liabilities | 296.589 M | 318.405 M | 317.573 M | 301.973 M | 297.946 M | 296.828 M | 307.387 M | |
| Total current liabilities | 46.000 M | 41.120 M | 42.023 M | 37.950 M | 34.739 M | 30.386 M | 46.294 M | |
| Accounts Payable | 8.768 M | 7.958 M | 11.505 M | 9.809 M | 2.854 M | 3.175 M | 12.330 M | |
| Other liabilities | 50.093 M | 46.601 M | 41.021 M | 48.449 M | 45.851 M | 46.958 M | 38.038 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 182.436 M | 184.976 M | 187.689 M | 167.031 M | 171.496 M | 176.164 M | 181.043 M | |
| Other liabilities | 50.093 M | 46.601 M | 41.021 M | 48.449 M | 45.851 M | 46.958 M | 38.038 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 127.549 M | 87.907 M | 75.766 M | 93.622 M | 76.960 M | 67.868 M | 58.957 M | |
| Common stock | 13.251 M | 16.783 M | 24.290 M | 24.504 M | 24.338 M | 1.242 M | 1.242 M | |
| Retained earnings | -894.879 M | -941.561 M | -955.415 M | -936.273 M | -953.097 M | -962.478 M | -971.366 M |